Sitting Down With... John Talley, Chief Scientific Officer at Euclises Pharmaceuticals, St. Louis, USA.

Grant Lindman is director of Eli Lilly’s global anticounterfeiting operations and is passionate about fighting fake medicines.

Recently, Tim Mackey and colleagues examined the extent to which counterfeit drugs had penetrated global legitimate supply chains.

Single-use technology is ready to lend a helping hand to biomanufacturing, but is the industry ready to turn away from stainless steel?

The EMA fights to reinstate its former executive director – and the FDA’s new leader is still unconfirmed

As the industry makes its video game debut, the big question is: will you prioritize patients over profit? Here’s our big review.

Expedited regulatory approvals bring medicines to market faster – but are they the right drugs?

Although our September cover feature focused on 3D printing, it is not the only printing technique that is being investigated in pharma applications.

What is 3D printing? Our 101 class will get yopu up to speed with the basics and history of the technique.

Earlier this year, a research group used 3D printing to give tablets a geometric makeover.